|
|
 |
您现在的位置:产品中心 >>
分子生化试剂 >> 生化试剂 |
BCL-2 CONVERTER,D-NUBCP-9-R8,CELL-PERMEA
产品编号: |
197320-2MG
查看说明书 |
产品名称:
|
BCL-2 CONVERTER,D-NUBCP-9-R8,CELL-PERMEA .0 订购此产品 |
供应商:
|
Merck |
规格: |
*** |
目录价: |
3,335.00 |
库存状态: |
3周到货 |
CAS编号:
|
|
应用范围: |
生化实验 |
种属来源: |
|
相关信息: |
|
Bcl-2 Converter, D-NuBCP-9-r8, Cell-permeable
(D)-Ac-fsrslhsll-G-NH(CH2)5-CO-rrrrrrrr-NH2, D-NuBCP-9
An all-D-amino acid version of the Nur77-derived minimum Bcl-2/Bcl-B/Bfl-1-conformation converting sequence is conjugated with a D-Arg octamer to facilitate its cellular delivery. CD binding studies reveal a 1:1 stoichiometric binding and that Bcl-2 unstructured loop region (aa 29-90) as the main D-NuBCP-9 interacting site with possible additional involvement of the BH4 domain. D-NuBCP-9-induced apoptosis is Bcl-2-dependent (100% vs 0% inhibition, respectively, of MEF vs Bcl-2-/- MEF colonies formation by 15 µM D-NuBCP-9) and requires the presence of either Bak or Bax (0% inhibition of Bax-/-Bak-/- MEF colonies formation). D-NuBCP-9-induced apoptosis in HeLa cultures is also demonstrated to be potentiated by 114% and 78%, respectively, upon vector expression of Bcl-B or Bfl-1. When applied to MDA-MB435-xenografted mice on the 10th & 13th day after cancer cell implant, D-NuBCP-9 (620 µg/mouse) reportedly suppressed tumor growth (by 80% on day 55) by inducing cancer cell apoptosis in vivo.
产品信息
Peptide Sequence (D)-Ac-phe-ser-arg-ser-leu-his-ser-leu-leu-Gly-NH-(CH2)5-CO-arg-arg-arg-arg-arg-arg-arg-arg-NH2
Form Lyophilized solid
Formulation Supplied as a trifluoroacetate salt.
Molar mass 2520.
Hygrocopic 是的
Packaged under inert gas 是的
Purity ≥95% by HPLC
Solubility H2O or DMSO
Chemical formula C106H191N49O23
商店和运输信息
Storage +2°C to +8°C
Ship Ambient Temperature Only
Standard Handling |
保存条件: |
2°C - 8°C |
说明书地址: |
点击查看详细 |
|
|
打印此页 关闭此页 |
上一个:BCL-2 BINDING PEPTIDE, NEG. CONTROL[197225-1MG/***]
下一个:BCL-2 INHIBITOR[197330-5MG/***]
|
|
 |
 |
|